LYPD1 Protein (Llama Fc Tag)

Produktnummer ABIN7482517

Produktdetails

Target: LYPD1 (Ly6/Plaur Domain Containing 1 (LYPD1))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses LYPD1 Protein ist gelabelt mit Llama Fc Tag.

Verwendungszweck: Human LYPD1 / PHTS Protein, Llama IgG2b Fc Tag, low endotoxin

Sequenz: Leu 21 - Gly 115

Produktmerkmale: Human LYPD1 Protein, Llama IgG2b Fc Tag is expressed from human 293 cells (HEK293). It contains AA Leu 21 - Gly 115 (Accession # Q8N2G4-1).

Reinheit: 90 %

Endotoxin-Niveau: 0.01 EU per μg

Anwendungsinformationen

Kommentare:

This protein carries a llama IgG2b Fc tag at the C-terminus. (LlamaFc(LlamaIgG2b) The protein has a calculated MW of 38.2 kDa. The protein migrates as 47-52 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: PBS, pH 7.4

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Antigendetails

Target: LYPD1 (Ly6/Plaur Domain Containing 1 (LYPD1))

Andere Bezeichnung: LYPD1 (LYPD1 Produkte)

Synonyme: LYPDC1 Protein, PHTS Protein, 2700050C12Rik Protein, AI853408 Protein, C530008O16Rik Protein, Lynx2 Protein, Lypdc1 Protein, LY6/PLAUR domain containing 1 Protein, Ly6/Plaur domain containing 1 Protein, LYPD1 Protein, Lypd1 Protein

Hintergrund: Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2-containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety.

Molekulargewicht: 38.2 kDa